Gracell Biotechnologies Inc. Quarterly Assets in USD from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Gracell Biotechnologies Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2023.
  • Gracell Biotechnologies Inc. Assets for the quarter ending June 30, 2023 was $190M, a 33% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $190M -$93.5M -33% Jun 30, 2023 6-K 2023-08-14
Q4 2022 $240M -$83.1M -25.7% Dec 31, 2022 20-F 2023-04-25
Q2 2022 $284M Jun 30, 2022 6-K 2022-08-15
Q4 2021 $323M +$175M +119% Dec 31, 2021 20-F 2022-04-22
Q4 2020 $148M Dec 31, 2020 20-F 2021-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.